The retinoblastoma tumor suppressor protein has been shown to bind directly and inhibit a transcriptionallyimportant amino-terminal kinase domain of TATAbinding protein-associated factor TAF II 250. Cyclin D1 also is able to associate with the amino terminus of TAF II 250 in a region very similar to or overlapping the Rb-binding site. In this study, we have examined whether cyclin D1 aects the functional interaction between Rb and TAF II 250. We observed that when cyclin D1 is coincubated with Rb and TAF II 250, the ability of Rb to inhibit TAF II 250 kinase activity is eectively blocked. However, cyclin D1 by itself has no apparent eect on TAF II 250 kinase activity. We further found that the Rbrelated protein p107 can inhibit TAF II 250 kinase activity, and this inhibition is likewise alleviated by cyclin D1. Cyclin D1 prevents the kinase-inhibitory eect of an Rb mutant unable to bind to D-type cyclins, indicating that it is acting through its association with TAF II 250 and not with Rb. However, we found no evidence of TAF II 250-binding competition between Rb and cyclin D1 in vitro. The adenovirus E1A protein, which also binds to both Rb and TAF II 250, exhibited a suppressive eect on Rb-mediated kinase inhibition similar to that seen with cyclin D1. Our results suggest a novel means by which cyclin D1 may be able to independently regulate the activity of Rb. Oncogene (2000) 19, 5703 ± 5711.
Introduction
The retinoblastoma tumor suppressor protein, Rb, serves as an important regulator of cell cycle progression by modulating the transcription of certain genes required for the G1 to S phase transition of the cell cycle (reviewed in Dyson, 1998; Weinberg, 1995) . Rb interacts physically or functionally with a variety of transcription factors and has been shown to either repress or stimulate promoter-speci®c transcriptional activity mediated by these factors (reviewed in Mulligan and Jacks 1998; Sanchez and Dynlacht, 1996) . Most models depict Rb as a passive regulator, indirectly aecting transcription only through its ability to interact with a particular transcription factor such as E2F (Flemington et al., 1993; Helin et al., 1993) . However, more recent evidence has suggested that Rb can function directly as a general repressor of activated transcription when targeted to a promoter, independent of an association with E2F (Adnane et al., 1995; Bremner et al., 1995; Sellers et al., 1995; Weintraub et al., 1995) , possibly through interaction with a component of the transcription initiation complex. Indeed, some ®ndings have indicated that Rb appears able to inhibit E2F-mediated transcription by recruiting the HDAC-1 histone deacetylase, thus aecting chromatin modi®cation (Brehm et al., 1998; Luo et al., 1998; Magnaghi-Jaulin et al., 1998) . In addition, we have demonstrated that Rb binds directly to the TATA-binding protein-associated factor TAF II 250 , and have established that the interaction is complex, involving multiple regions of both Rb and TAF II 250 (Shao et al., 1997) .
TAF II 250 is the largest of approximately 10 TAF subunits of Pol II-speci®c human TFIID (Hahn, 1998; Tansey and Herr, 1997) . It binds directly to TBP as well as several other TAFs, and is believed to be the central scaold for assembly of the TAFs and TBP into a stable TFIID complex (Weinzierl et al., 1993) . TAF II 250 possesses intrinsic histone acetyltransferase activity (Mizzen et al., 1996) , as well as protein kinase activity (Dikstein et al., 1996) . The kinase is bipartite, consisting of N-and C-terminal kinase (NTK and CTK) domains, and is capable of both autophosphorylation and speci®c transphosphorylation of the RAP74 subunit of the general transcription initiation factor TFIIF (Dikstein et al., 1996) . TAF II 250 is believed to play an important role in modulating progression through the G1 phase of the cell cycle (Hisatake et al., 1993) . A temperature-sensitive mutation (Gly690Asp) in TAF II 250 in the ts13 hamster cell line induces G1 arrest at the nonpermissive temperature (Hayashida et al., 1994) , in part through downregulation of D-type cyclin expression and upregulation of p21 expression (Rushton et al., 1997; Suzuki-Yagawa et al., 1997) . Promoter-selective transcriptional defects have been identi®ed in ts13 cells, speci®cally a marked decrease in expression from the cyclin A promoter, which is rescued by wild-type human TAF II 250 (Wang and Tjian, 1994) . Transcription of both cyclins A and D1 appears to be directly aected by the ts13 mutation in TAF II 250 (Sekiguchi et al., 1999) , and evidence suggests that TAF II 250 kinase activity, speci®cally that of the NTK domain, is required for transcription of cyclin A, cdc2, and cyclin D1, as well as for ecient rescue of G1 arrest in ts13 cells (O'Brien and Tjian, 1998) . Very recently, it has been shown that the histone acetyltransferase and kinase activities of TAF II 250 modulate expression of distinct subsets of mammalian genes, with the kinase activity apparently necessary for expression of approximately 6% of genes in ts13 cells and the acetyltransferase activity needed for expression of a dierent set of genes, constituting approximately 1% of the ts13 genes (O'Brien and Tjian, 2000) . Interestingly, we have demonstrated that the Rb protein can directly inhibit the kinase activity of TAF II 250, through its interaction with the amino terminus of TAF II 250 (Siegert and Robbins, 1999) .
We have also recently shown that cyclin D1 is able to associate with TAF II 250 (Adnane et al., 1999) . The D-type cyclins, together with cyclin-dependent kinases, are known to regulate transcription by inactivating Rb through phosphorylation (reviewed in Hunter and Pines, 1994) . However, cyclin D is apparently also able to regulate transcription directly, independent of a partner cdk. For example, cyclin D1 has been shown to stimulate transcription mediated by the estrogen receptor through a direct association (Neuman et al., 1997; Zwijsen et al., 1997) , though it remains unclear whether D1 acts solely through the estrogen receptor or whether it also interacts with the transcription initiation machinery. In addition, D-type cyclins have been shown to override, in a cdk-independent manner, gene expression and cell cycle arrest mediated by DMP1, a novel S phase-regulatory transcription factor (Inoue and Sherr, 1998) .
In this study we further examine the binding of cyclin D1 to TAF II 250 and analyse the eects of D1 on TAF II 250 kinase activity and kinase inhibition by Rb in vitro. We establish that Rb and cyclin D1 bind to a very similar, perhaps overlapping, region at the amino terminus of TAF II 250. In kinase assays using puri®ed proteins, we demonstrate that cyclin D1 is able to suppress the ability of Rb to inhibit TAF II 250 kinase activity, but alone has no direct eect on TAF II 250 kinase activity. In addition, the Rb-related protein p107, which is also able to inhibit the kinase activity of TAF II 250, is similarly aected by cyclin D1. Although cyclin D1 appears to be aecting Rb-mediated kinase inhibition through its interaction with TAF II 250 rather than with Rb, our ®ndings suggest that Rb and cyclin D1 do not compete for binding to TAF II 250. Taken together, these results indicate a novel means by which cyclin D1 may be able to directly modulate the transcription-regulatory activity of Rb.
Results
Cyclin D1 and Rb bind to a similar region at the amino terminus of TAF II 250
It has been previously shown that Rb and hTAF II 250 can interact through multiple domains in each protein, including the amino terminus of TAF II 250 (Shao et al., 1997) . It has also been demonstrated that cyclin D1 is able to bind to the amino terminus of hTAF II 250 (Adnane et al., 1999) , though these latter studies were performed primarily through co-transfection assays and not with puri®ed proteins. We examined the Rb-and TAF II 250-binding properties of puri®ed cyclin D1 in vitro, using a baculovirus-expressed, GST-tagged, murine cyclin D1 protein. This GST-cycD1, puri®ed from Sf9 cell lysates, was immobilized on glutathioneSepharose beads and incubated with in vitro expressed,
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S-labeled GAL4-Rb or HA-TAF II 250, both full-length. As controls, bacterially-expressed GST-Rb 379 ± 928 (large pocket) and/or baculovirus-expressed GST were also tested for binding in each assay. GST-D1 bound eciently to in vitro expressed Rb (Figure 1a) , and it bound to TAF II 250 ( Figure 1b , lane 2) with only slightly less eciency than did GST-Rb 379 ± 928 (lane 4). The amounts of the GST-D1 and GST-Rb 379 ± 928 present were roughly equal (data not shown).
To further map the binding site for cyclin D1 within TAF II 250, several nested N-terminal fragments of TAF II 250 (from the amino terminus to residue 450) were utilized, as it had been previously determined that cyclin D1 does not interact with the C-terminal end of TAF II 250 (residues 450 ± 1893; data not shown). The amino terminal sequences were expressed in vitro as 35 Slabeled proteins and analysed for binding to both GST-Rb 379 ± 928 (bacterially-expressed) and GST-cycD1 (baculovirus-expressed). As is shown in Figure 1c , both cyclin D1 (lane 2) and Rb (lane 4) bound eciently to TAF II 250 residues 1 ± 434. However, TAF II 250 Nterminal fragments below amino acid 434 failed to Figure 1 Cyclin D1 and Rb bind similarly to the N-terminus of TAF II 250. (a) Baculovirus-expressed GST-cyclin D1 or GST (control) were bound to glutathione-Sepharose, incubated with in vitro expressed, radiolabeled GAL4-Rb 10 ± 928 and subjected to SDS ± PAGE and autoradiography. Ten per cent input indicates an amount of the radiolabeled Rb protein equal to 10% of the amount that was incubated with D1 or GST. (b) The same baculovirus-expressed GST-cyclin D1 or GST was immobilized and incubated with in vitro expressed, radiolabeled, full-length TAF II 250, as was bacterially-expressed GST-Rb 379 ± 928 . Bound proteins were subjected to SDS ± PAGE and autoradiography. Ten per cent input indicates 10% of the amount of radiolabeled TAF II 250 that was used per reaction. (c) Same as described for (b), except this time using just the ®rst 434 amino acids of TAF II (Figure 2 ), though such a possibility has not been determined conclusively.
Cyclin D1 alleviates Rb-mediated repression of TAF II 250 kinase activity
Because the interaction of Rb with the N-terminus of TAF II 250 aects the kinase activity intrinsic to that region, we wanted to determine whether the binding of cyclin D1 to a similar region of TAF II 250 also aected kinase activity. A modi®ed version of the denaturationrenaturation assay described by Dikstein et al. (1996) was used, as described previously (Siegert and Robbins, 1999) , in order to ensure the use of a highly puri®ed form of TAF II 250. Baculovirus-expressed HAhTAF II 250 was immunopuri®ed from Sf9 cell extract, divided into equal aliquots, subjected to SDS ± PAGE, and transferred to nitrocellulose. The region of the membrane containing TAF II 250, as judged by Ponceau S staining and prior Western analysis of a duplicate membrane (see Materials and methods), was excised, incubated in a denaturing solution, and then renatured overnight. As a negative control, the corresponding region of membrane was also cut from a lane loaded only with Laemmli buer, and this was subsequently subjected to the same conditions as the TAF II 250-containing membrane slice. Note that this control has been previously tested and was found to give results identical to those achieved by cutting a corresponding region of membrane from a lane loaded with extract from mock-infected Sf9 cells (Siegert and Robbins, 1999) . The TAF II 250-containing slices were then incubated either alone or in the presence of a variety of combinations of puri®ed GST-Rb (large pocket), GST-cyclin D1, and GST. Membrane slices were then washed and tested for kinase activity after adding puri®ed RAP74 protein as substrate, and radiolabeled ATP.
As shown in Figure 3 , the addition of Rb alone to the TAF II 250 membrane slice (lane 3) resulted in a signi®cant reduction in the kinase activity of TAF II 250, as has been previously demonstrated (Siegert and Robbins, 1999) . However, when TAF II 250 was incubated with both Rb and cyclin D1 (Figure 3 , lane 4), Rb was no longer able to inhibit the phosphorylation of RAP74 by TAF II 250. The addition of cyclin D1 alone to TAF II 250 had no signi®cant eect on kinase activity ( Figure 3 , lane 5), whereas GST had no signi®cant eect on Rb-mediated inhibition of kinase activity (lane 6). The addition of higher doses of cyclin D1 did not increase RAP74 phosphorylation beyond the level seen for TAF II 250 alone (data not shown). Figure 3 Cyclin D1 suppresses the ability of Rb to inhibit TAF II 250 kinase activity. Nitrocellulose-immobilized TAF II 250, puri®ed as described in the text, was tested for the ability to phosphorylate puri®ed, recombinant RAP74, either alone (lane 2) or after incubation with puri®ed, recombinant GST-Rb 379 ± 928 (lane 3), with both puri®ed Rb and GST-cyclin D1 together (lane 4), with puri®ed D1 alone (lane 5), with both puri®ed Rb and GST together (lane 6), or with puri®ed GST alone (lane 7). The mock reaction (lane 1) contained a`blank' piece of nitrocellulose with no TAF II 250 as described in the text. Reactions were subjected to SDS ± PAGE and autoradiography (top part of ®gure, representative of four separate, duplicate assays). Resultant radioactive counts were quantitated on a radioanalytic imager and averaged together with those from the three additional assays (bar graph at bottom), and are presented relative to the mock reaction which was set to 1. Error bars indicate standard error Adenovirus E1A protein is also able to relieve TAF II 250 kinase inhibition by Rb Adenovirus E1A is a tumor virus oncoprotein known to bind and inactivate Rb (Whyte et al., 1988) , and has also been shown to interact with TAF II 250 (Geisberg et al., 1995) . Within TAF II 250, E1A binds near the C-terminus in a region that partially overlaps the RAP74-binding site (refer back to Figure  2 ), which is independent from the Rb-and D1-binding sites at the N-terminus of TAF II 250. As a means of establishing biological relevance both for TAF II 250 kinase inhibition by Rb and its suppression by cyclin D1, we sought to determine whether E1A could aect Rb-mediated kinase inhibition similarly to cyclin D1. When tested in an assay identical to that described above for Figure 3 , puri®ed recombinant E1A 13S (bacterially-expressed, GST-tagged) was indeed able to alleviate TAF II 250 kinase inhibition by Rb (Figure 4 , column 5), albeit not quite to the extent that cyclin D1 suppressed kinase inhibition (column 4). Thus E1A, a protein which is known to inactivate the tumor suppressive actions of Rb, is able to override the functional interaction between Rb and TAF II 250. However, because E1A binds to a completely dierent region of TAF II 250 than both Rb and cycD1, its mechanism for relieving kinase inhibition by Rb may be dierent from that of cycD1.
p107 inhibits TAF II 250 kinase and is likewise suppressed by cyclin D1
The retinoblastoma protein family is comprised of three pocket-containing proteins involved in limiting cell cycle progression. These proteins, Rb, p107, and p130, are able to interact with a similar set of proteins and share certain overlapping functions. In particular, it has been previously shown that all three members of the Rb family are able to interact with TAF II 250 (Shao et al., 1997) . Our aim was speci®cally to examine whether p107 was able to aect TAF II 250 kinase activity similar to Rb. Just as the large pocket domain of Rb is able to bind at or near the amino terminal kinase domain of TAF II 250, the homologous large pocket domain of p107 is also able to bind this same region of TAF II 250 (data not shown). We tested puri®ed recombinant GST-p107 385 ± 1069 (large pocket) in the same assay described above for Figure 3 . We found that p107 was indeed able to inhibit TAF II 250 kinase activity (Figure 4 , column 6), to essentially the same degree as did Rb (column 3). In addition, when puri®ed cyclin D1 was incubated together with p107 and TAF II 250, p107-mediated kinase inhibition was alleviated (column 7) comparable to that seen for Rb (column 4). Thus, at least two members of the Rb protein family are able to interact functionally with TAF II 250, and their activity appears to be modulated by cyclin D1. However, cyclin D1 has not been shown to stably bind to p107 (Ewen et al., 1993) , which would suggest that cyclin D1 is antagonizing p107-mediated kinase inhibition through its interaction with TAF II 250.
Binding of cyclin D1 to Rb is not required to block Rb-mediated inhibition of TAF II 250
In contrast to p107, both Rb and TAF II 250 are able to bind eciently to cyclin D1, and therefore D1 could potentially be aecting Rb-mediated kinase inhibition either through interaction with Rb or with TAF II 250. To distinguish between the two possibilities, we used a puri®ed, recombinant Rb pocket mutant (Rb DD ; 379 ± 928, D678) which has been characterized for several important properties. The Rb DD mutant is able to bind eciently to TAF II 250 in vitro (Figure 5a ). However, Rb DD is no longer able to bind to cyclin D1 in vitro (Figure 5b , lanes 4 and 7) nor to other D-type cyclins (data not shown). In addition, a full-length version of this same Rb mutant migrates as a single band when compared to wild-type Rb after expression in U2-OS cells (Figure 5c ), suggesting that Rb DD is not phosphorylated. Moreover, the Rb DD mutant does not bind to E1A, consistent with our ®nding of a perfect correlation between E1A binding and D-type cyclin binding amongst other characterized Rb mutants (data not shown). Our preliminary studies had demonstrated that this Rb mutant maintained the ability to inhibit TAF II 250 kinase activity. Using the assay as described for Figure 3 , we tested the ability of cyclin D1 to aect in vitro kinase inhibition by Rb DD . As shown in Figure 5d , despite its apparent inability to bind or phosphorylate Rb DD , cyclin D1 remained completely capable of alleviating (column 6) the inhibition of TAF II 250 kinase activity by this Rb mutant (column 5). Thus, our results suggest that Figure 4 Eects of adenovirus E1A on Rb-mediated kinase inhibition, and cyclin D1 on p107-mediated kinase inhibition. Identical reactions to those described in Figure 3 were performed, with the addition of reactions in which nitrocellulose-bound TAF II 250 was incubated with both puri®ed GST-Rb 379 ± 928 and GST-E1A 13S (column 5), or with puri®ed GST-p107 385 ± 1069 (column 6), or with both puri®ed p107 and GST-cycD1 (column 7). Each reaction was then tested for the ability to phosphorylate RAP74, and the quantitated radioactive counts of three separate, duplicate assays were averaged and are presented relative to mock (column 1), which was set to 1. Error bars represent standard error cyclin D1 is not inactivating Rb-mediated kinase inhibition through either binding or phosphorylation of Rb, but rather by its interaction with TAF II 250. This ®nding is also consistent with the similar result seen for p107, described above, which was presumed to be due to the D1/TAF II 250 interaction since p107 does not bind eciently to cyclin D1 (Ewen et al., 1993) .
Cyclin D1 does not appear to compete with Rb for binding to TAF II 250
One mechanism by which cyclin D1 might be aecting Rb-mediated kinase inhibition is through competitive binding to TAF II 250. Such a model would be supported by the possibility that Rb and cyclin D1 may bind to overlapping sites at the N-terminus of TAF II 250 (Figure 1) . It has been previously reported that in co-infection assays, an increasing dose of an Rb-expressing baculovirus, co-infected with baculoviruses expressing TAF II 250 and cyclin D1, could apparently reduce the amount of cyclin D1 and TAF II 250 found complexed following immunoprecipitation (Adnane et al., 1999) . This result suggested that Rb was competing with cyclin D1 for binding to TAF II 250. However, because the assay was performed transiently in vivo, there remain many variables that could not be controlled for, including the potential role of secondary interactions between any of the three overexpressed proteins and the multitude of additional endogenous proteins with which they are known to associate.
We utilized a partially-puri®ed in vitro system to examine TAF II 250-binding competition between Rb and cyclin D1. Full-length, baculovirus-expressed Rb was immunopuri®ed from Sf9 cell lysate onto protein A-Sepharose beads. As a control, a mock-infected Sf9 lysate was subjected to identical immunopuri®cation and subsequent experimental conditions. The Rb protein was then incubated either with in vitro expressed,
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S-labeled TAF II 250 alone, or with TAF II 250 plus an increasing concentration of puri®ed, baculovirus-expressed GST-cyclin D1, or alternatively with TAF II 250 plus puri®ed GST as a control. Beadbound protein complexes were then washed and subjected to SDS ± PAGE, followed by autoradiography or Western analysis (Figure 6) . Compared to the level of TAF II 250 bound to Rb alone (top panel, lane 1) the addition of cyclin D1, even at the highest dose (lane 4), had no apparent eect on complex formation between TAF II 250 and Rb ( Figure 6 , lanes 2 ± 4). Western analysis of the bottom half of the same gel, using a monoclonal anti-cyclin D1 antibody, showed an increasing amount of cyclin D1 complexed with Rb and TAF II 250 (bottom panel, lanes 2 ± 4). To address the possibility in these assays that a sucient amount of Rb had remained free of TAF II 250 and able to bind all of the added cyclin D1, we performed several duplicate assays using limiting amounts of Rb, yet continued to see the same results (data not shown). Similar results were obtained in assays utilizing bacterially-expressed GST-Rb 379 ± 928 which had been anity-puri®ed prior to immunoprecipitation with anti-Rb/protein A beads (data not shown). Thus, in vitro, cyclin D1 and Rb do not appear to compete for binding to TAF II 250.
Discussion
In addition to the cdk-dependent role of modulating Rb activity through phosphorylation, D-type cyclins also appear to be capable of regulating transcription directly. Speci®cally, cyclin D1 has been shown to repress both Sp1-and MyoD-mediated transcription Figure 5 Interaction between cyclin D1 and Rb is not necessary for alleviation of kinase inhibition. (a) Bacterially-expressed and bead-immobilized GST, GST-Rb 379 ± 928 , or GST-Rb DD (amino acids 379 ± 928 of Rb, with a mutation at amino acid 678) was incubated with in vitro expressed, radiolabeled full-length TAF II 250. Reactions were subjected to SDS ± PAGE and autoradiography.`Input' represents 10% of the amount of labeled TAF II 250 used per reaction. (b) Rb DD does not bind to cycD1 in vitro. Lanes 1 ± 4: baculovirus-expressed and puri®ed GST-cycD1 was immunoprecipitated with an a-D1 antibody and protein ASepharose, then incubated with bacterially-expressed and puri®ed Rb pocket protein, either GST-Rb (lane 3) or GST-Rb DD (lane 4). Inputs' in lanes 1 and 2 represent 10% of the amount of Rb or RB DD added to the reaction. Lanes 5 ± 7: bacterially-expressed and puri®ed GST-Rb (lane 6) or GST-Rb DD (lane 7) was immunoprecipitated with an a-Rb antibody and protein ASepharose, then incubated with baculovirus-expressed and puri®ed GST-cycD1.`Input' in lane 5 represents 10% of the amount of cyclin D1 added per reaction. (c) To examine protein modi®cation in vivo, pSG5L-HA-Rb (wild-type, full-length) or pSG5L-HA-Rb DD [full-length version of same D678 Rb mutant used in (a and b)] was expressed in U2-OS cells by transfection. Recombinant Rb proteins were then detected by immunoprecipitation and Western blot with an anti-HA antibody, and relative band migration patterns were compared. (d) The kinase activity of nitrocellulose-bound TAF II 250 was assayed as described in Figure  3 , with the inclusion of reactions in which TAF II 250 was preincubated with puri®ed GST-Rb DD (column 5), or with both puri®ed Rb DD plus GST-cyclin D1 (column 6). Radioactive counts present in RAP74 after the kinase reaction were quantitated from a total of three separate, identical assays, and are presented here as averaged results relative to the mock reaction (column 1), which was set to 1. Error bars indicate standard error (Gu et al., 1993; , and has also been demonstrated to stimulate transcription mediated by the estrogen receptor through a direct association, independent of cdk4 (Neuman et al., 1997; Zwijsen et al., 1997) . Particularly interesting is the ®nding that, independent of cdks, D-type cyclins inhibit S phase-regulatory gene expression and cell cycle arrest mediated by DMP1, a novel transcription factor (Inoue and Sherr, 1998) . Moreover, it has recently been shown that cyclin D1 is able to associate with the TAF II 250 subunit of the basal transcription factor TFIID (Adnane et al., 1999) . In this study we have further characterized the interaction between cyclin D1 and TAF II 250, and have demonstrated a functional consequence of this interaction.
Both Rb and cyclin D1 are able to interact with amino terminal sequences of TAF II 250 (Adnane et al., 1999; Shao et al., 1997) . Mapping analyses demonstrated that Rb and cyclin D1 appear to bind to a very similar, perhaps overlapping, site at the amino terminus of TAF II 250 (Figures 1 and 2 ), though this cannot be said conclusively. When we examined a series of nested amino-terminal fragments of TAF II 250, cyclin D1 was able to interact, to some degree, with every region of TAF II 250 that bound to Rb, though usually with a lower anity (data not shown). Testing the eect of cyclin D1 in kinase assays with TAF II 250 and Rb in vitro, we found that while cyclin D1 alone had no apparent eect on TAF II 250 kinase activity, it was able to suppress the ability of Rb to inhibit that kinase activity (Figure 3) . Because puri®ed, recombinant proteins were used in these assays, the observed eects of cyclin D1 are not believed to be due to the presence of a cyclin-dependent kinase. Thus, in the presence of cyclin D1, Rb was no longer able to inhibit TAF II 250 kinase activity, apparently due to some direct eect of cyclin D1 itself.
TAF II 250 is capable of both autophosphorylation as well as transphosphorylation of the RAP74 subunit of TFIIF (Dikstein et al., 1996) , and Rb inhibits both of these activities (Siegert and Robbins, 1999) . For the assays presented here, we focused on RAP74 phosphorylation. The ability of RAP74 to support transcription indeed appears to be regulated by phosphorylation (Kitajima et al., 1994) and to date, RAP74 appears to be the only basal transcription factor which interacts directly with TAF II 250 (Ruppert and Tjian, 1995) . The N-terminal, central, and Cterminal regions of RAP74 have been shown to play distinct roles during separate phases of the transcription cycle (Lei et al., 1998) . Also of interest is our prior ®nding that Rb speci®cally inhibits the N-terminal kinase (NTK) domain of TAF II 250 (Siegert and Robbins, 1999) , one of two present in TAF II 250 (Dikstein et al., 1996) . Studies have suggested that NTK activity of TAF II 250 is required to direct transcription of certain genes in vivo, including those for cyclin A, Cdc2, and cyclin D1 (O'Brien and Tjian, 1998) . Thus, while the inhibition of TAF II 250-mediated RAP74 phosphorylation by Rb may represent a novel mechanism of transcriptional regulation, the suppression of this Rb activity by cyclin D1 suggests a novel, cdk-independent role for D1 in modulation of Rbregulated transcription.
Interestingly, the E1A protein, a known repressor of Rb activity, was also able to relieve kinase inhibition by Rb (Figure 4) . E1A binds to both Rb and TAF II 250, just as cyclin D1 does; however, E1A binds to a C-terminal region of TAF II 250 near the RAP74-binding site (Geisberg et al., 1995) , while D1 binds to the N-terminus of TAF II 250. Thus, the mechanism by which E1A is suppressing Rb-mediated inhibition of TAF II 250 kinase activity may be dierent than that used by cyclin D1. It remains to be tested whether E1A is aecting kinase inhibition through its interaction with Rb or with TAF II 250. However, the observation that two dierent biologically-relevant modulators of Rb activity, cyclin D1 and adenovirus E1A, are able to comparably aect the Rb/TAF II 250 functional interaction suggests a biological signi®cance for this activity of Rb. In addition, we were further able to demonstrate that the Rb-related pocket protein p107 also inhibited TAF II 250 kinase activity similarly to Rb, and this inhibition was likewise alleviated by cyclin D1 (Figure 4) . Our ®nding that another member of the Rb-related protein family possesses the same ability to inhibit TAF II 250 kinase activity, and that the same, highly-conserved pocket region of each protein is involved, further supports the biological relevance of the Rb/TAF II 250 functional interaction and its modulation by cyclin D1. p107 has also been shown to inhibit the kinase activity of cyclin-cdk2 complexes (Woo et al., 1997) , however Rb is unable to inhibit cdks (Castano et al., 1998) . p107 does not inhibit cyclin D-cdk4 kinase activity (Castano et al., 1998) , nor does it appear to stably bind to cyclin D1 (Ewen et Figure 6 Cyclin D1 and Rb do not appear to compete for binding to TAF II 250. Full-length, baculovirus-expressed Rb was immunoprecipitated from Sf9 cell extract using an anti-Rb antibody and protein A-Sepharose. This Rb was then incubated either alone with in vitro expressed, radiolabeled TAF II 250 (lane 1), or with TAF II 250 plus increasing amounts of puri®ed GSTcyclin D1 (lanes 2 ± 4), or with TAF II 250 plus GST (lane 5). A mock reaction was also included (lane 6), in which an uninfected Sf9 cell lysate was subjected to identical immunoprecipitation with anti-Rb and incubation with TAF II 250 (lane 6). Reactions were subjected to SDS ± PAGE, the gel was cut, and the top half was analysed by autoradiography while the bottom half was blotted and probed with an antibody to cyclin D1. The position of GST-cycD1 in the bottom Western is indicated by an asterisk. The IgG band present in each lane is from the original immunoprecipitation of Rb. Ten per cent max. input cyclin D1 indicates 10% of the amount of puri®ed D1 added to the reaction in lane 4 al., 1993), which suggests that the ability of cyclin D1 to antagonize p107-mediated inhibition of TAF II 250 kinase activity depends upon the interaction of D1 with TAF II 250 rather than with p107.
As evidence that cyclin D1 aects Rb-mediated kinase inhibition through its interaction with TAF II 250 rather than with Rb, we have demonstrated that kinase inhibition by a mutant Rb protein, Rb DD , is eciently suppressed by D1 (Figure 5 ). This Rb mutant retains its ability to interact with TAF II 250, though it is not bound by nor apparently phosphorylated by D-type cyclins. Such a ®nding suggests that the alleviation of Rb-mediated kinase inhibition in the presence of cyclin D1 is not due to an inactivating phosphorylation of Rb by some contaminating cdk that possibly copuri®ed with the cyclin D1 used in the assays.
Although cyclin D1 appears to be acting to block kinase inhibition through its interaction with TAF II 250, we did not ®nd evidence that cyclin D1 competes with Rb for binding to TAF II 250 (Figure 6 ). This ®nding was somewhat unexpected since Rb and D1 appear to be binding to such a similar region at the amino terminus of TAF II 250. Though it is true that Rb binds to more than one region of TAF II 250, we do not believe this would account for a lack of apparent binding competition to a full-length TAF II 250 construct, since the strongest interaction with Rb is at the amino terminus of TAF II 250 (Shao et al., 1997) . The fact that the eect of cyclin D1 on Rb-TAF II 250 appears not to involve direct binding competition suggests a more complex mechanism for regulation. It is possible that, while the binding of D1 to TAF II 250 does not seem to preclude an interaction between Rb and TAF II 250, binding of D1 to the amino terminus of TAF II 250 may alter the conformation of the NTK domain in such a way that Rb is no longer able to inhibit its kinase activity. We have previously shown that binding alone is apparently not sucient for Rb to inhibit TAF II 250 kinase activity, since several dierent Rb mutants which still bound eciently to the amino terminus of TAF II 250 were functionally defective for kinase inhibition (Siegert and Robbins, 1999) . This led us to propose a model in which Rb, once bound to the amino terminus of TAF II 250, is either negatively altering the conformation of the kinase domain or physically blocking the active site of the kinase (Siegert and Robbins, 1999) . Cyclin D1 may be aecting one of these latter stages of kinase inhibition by Rb, rather than the initial binding step. Further studies will be necessary, using several combinations of binding mutants of cyclin D1, Rb, or TAF II 250, in order to better de®ne a mechanism.
Interestingly, it has recently been demonstrated that for transcriptional repression of E2F, Rb appears to function during preinitiation complex formation, possibly interfering with the recruitment, assembly, or stability of a TFIIA/TFIID complex in a manner dependent upon the presence of TBP-associated factors (TAFs) (Ross et al., 1999) . These assays were performed using a chromatin-free system, thus obviating a need for recruitment of histone-modifying enzymes such as HDAC1, a mechanism for Rb transcriptional regulation previously suggested by several studies (Brehm et al., 1998; Luo et al., 1998; Magnaghi-Jaulin et al., 1998) . Indeed, we have observed TAF II 250 kinase inhibition by an Rb mutant which does not bind to HDAC1, yet still represses transcription and causes G1 arrest (data not shown). Thus, it will be important to continue to characterize the inhibition of TAF II 250 kinase activity by Rb, as well as its modulation by cyclin D1, in order to determine the role that such activities might play in regulation of transcription, the cell cycle, and ultimately, tumorigenesis.
Materials and methods

Plasmid constructs
The T7 expression vector (pET-3b, obtained from M Schmidt) encoding GAL4-Rb expresses amino acids 10 ± 928 of Rb fused to GAL4 1 ± 147 (Adnane et al., 1995) . GST and GST-mCycD1 baculoviruses were obtained from M Ewen. The GST fusion construct for bacterial expression of Rb 379 ± 928 were created as described (Kaelin et al., 1991) . The T7 expression vectors encoding either full-length hTAF II 250 (pTb-STOP) or N-terminal fragments of hTAF II 250 (pET-HAX) were provided by R Tjian and S Ruppert, respectively (Ruppert and Tjian, 1995; Ruppert et al., 1993) . The baculovirus encoding HA-hTAF II 250 was obtained from S Ruppert (Ruppert and Tjian, 1995) . Histidine-tagged RAP74 was expressed from pET-23d in bacteria, and was provided by Z Burton (Finkelstein et al., 1992) . The construct for expression of GST-E1A 13S in bacteria was provided by D Rowe. The construct for bacterial expression of GST-p107 385 ± 1069 was made by inserting BamHI/SmaI-digested (PCR-created sites) cDNA encoding amino acids 385 ± 1069 of p107, from GAL4-p107 (provided by J Adnane), into BamHI/SmaI-cut pGEX-2T (Pharmacia). PSG5L is a derivative of pSG5 (Stratagene) with a modi®ed polylinker (R Scully and DM Livingstone, unpublished). HA-tagged full-length (wild-type) Rb was introduced into pSG5L as described (Sellers et al., 1998) , and from this construct HA-Rb DD (D678) was made by sitedirected mutagenesis. A GST-tagged version of Rb DD containing only the large pocket of Rb (a.a. 379 ± 928, D678) was generated accordingly. The baculovirus encoding full-length, untagged Rb has been previously described .
Protein binding assays
For studies examining the binding of cyclin D1 to Rb, TAF II 250, and N-terminal fragments of TAF II 250 ( Figure  1) , 35 S-labeled ( 35 S-Met, 1000 Ci/mmol; Amersham) GAL4-Rb or hTAF II 250 (full-length and N-terminal pieces) was produced in vitro using a TnT-T7 protein expression kit (Promega), with 1 mg of input plasmid DNA per 50 ml kit reaction. GST-fusion proteins were expressed in either DH5a E. coli (Rb 379 ± 928 ) or in Sf9 cells (GST and GSTcycD1), isolated, and immobilized on glutathione-Sepharose 4B (Pharmacia), as previously described (Shao et al., 1997; Siegert and Robbins, 1999) . Binding reactions were performed as previously described (Siegert and Robbins, 1999) , and consisted of 250 ml Binding buer 1 (10 mM HEPES, pH 7.4; 200 mM NaCl; 0.5 mM EDTA; 0.5 mM DTT; 0.1% NP-40) with protease inhibitors (1 mg/ml aprotinin, 1 mg/ml leupeptin, 50 mg/ml PMSF) and 3 mg/ ml BSA, plus 10 ml of labeled TAF II 250 or Rb product. After incubating (with rotation) at RT for 45 min, beads were washed 46 with Binding buer 1, resuspended in Laemmli sample buer, and subjected to SDS ± PAGE and autoradiography. Ten per cent (1 ml) of the input labeled protein was included on the gel for comparison. For the assay examining the binding of GST-Rb DD to in vitro expressed TAF II 250 (Figure 5a) , the indicated GST-tagged proteins were bacterially-expressed and immobilized as described above. The radiolabeled TAF II 250 for this assay was produced in vitro, also as outlined above, and the binding reactions were carried out in the same manner as well. To test the binding of GST-Rb DD to GST-cyclin D1 (Figure 5b ), two dierent methodologies were employed. In one, baculovirus-expressed GST-cycD1 that had been previously puri®ed o of glutathione-Sepharose beads was immunoprecipitated using a 1 : 1000 dilution of anti-D1 monoclonal antibody (Ab-3, CalBiochem). After overnight incubation at 48C, immune complexes were immobilized onto protein A-Sepharose (Sigma; 50% v : v in Binding buer 1 plus 3 mg/ml BSA) for 1 h at 48C. Washed, beadbound D1 was then incubated with bacterially-expressed, puri®ed GST-Rb 379 ± 928 or GST-Rb DD (construct described above) in 250 ml Binding buer 1 with 50 mg/ml PMSF and 3 mg/ml BSA, for 45 min at RT. Bead-bound protein complexes were then processed for analysis as previously described (Siegert and Robbins, 1999) . After SDS ± PAGE and transfer to nitrocellulose, the blot was probed with either anti-Rb polyclonal antibody (C-15, Santa Cruz Biotechnology; top half of blot), or anti-D1 monoclonal antibody to verify equal levels of cycD1 per reaction (bottom half of blot). As an alternative to this method, the`reverse' set-up was performed: puri®ed GST-Rb or RB DD protein was immunoprecipitated as GST-D1 had been, using a 1 : 1000 dilution of anti-Rb polyclonal antibody and protein A-Sepharose. Washed, bead-bound Rb or Rb DD was then incubated with puri®ed GSTcyclin D1 under the same binding conditions as described above. Reactions were run on the same gel as the`reverse' reactions, and thus were analysed identically (Western blot, probing the top half with anti-Rb and the bottom with anti-D1).
For the competition binding assay (Figure 6 ), baculovirusexpressed full-length Rb protein was immunoprecipitated from Sf9 cell extract, prepared as described (Adnane et al., 1999) , using a 1 : 1000 dilution of anti-Rb polyclonal antibody. Incubation and immobilization on beads was carried out as described above. A mock reaction was also set up, consisting of an uninfected Sf9 cell lysate subjected to immunoprecipitation conditions identical to those used for Rb. Equally-divided aliquots of bead-immobilized Rb was then incubated for 45 min at RT in 250 ml Binding buer 1 with protease inhibitors and BSA, with either 35 S-TAF II 250 (produced in vitro, as described above) alone, or 35 S-TAF II 250 plus increasing amounts of puri®ed GST-cyclin D1 (puri®cation described below). Beads were then washed extensively and protein complexes were subjected to SDS ± PAGE, the gel was cut and the top portion of the gel was autoradiographed to visualize the TAF II 250 band, while the bottom portion of the gel was processed for Western analysis to visualize the levels of bound cyclin D1.
Kinase assays
Kinase reactions were an adaptation of the denaturation/ renaturation assays performed by Dikstein et al. (1996) , and have been previously described in great detail (Siegert and Robbins, 1999) . The only dierence in the assays presented here is the inclusion of additional puri®ed proteins (e.g. GSTcycD1, GST-E1A, or GST-p107) in the binding step prior to the kinase reaction, as noted for each relevant ®gure. In each reaction, these puri®ed proteins were present in approximately equal concentrations to one another. In addition, in reactions having more than one puri®ed protein incubated together with TAF II 250, both of the puri®ed proteins were added at about the same time, one immediately after the other.
Protein purification
His-tagged RAP74 was bacterially-expressed and puri®ed over a Ni 2+ -NTA resin (Qiagen), as previously described (Siegert and Robbins, 1999) . GST-Rb 379 ± 928 , GST-Rb DD1 , GST-E1A 13S , and GST-p107 385 ± 1069 were bacterially-expressed and puri®ed over a glutathione-Sepharose 4B resin (Pharmacia), as previously described (Siegert and Robbins, 1999) . Baculovirus-expressed GST and GST-cycD1 were puri®ed according to the same scheme used for other GSTtagged proteins, except that they were produced in Sf9 cells and lysates were made accordingly (Adnane et al., 1999) . Aliquots of column fractions from each puri®cation were subjected to analysis by both Coomassie-staining for total protein, as well as Western blotting with antibodies speci®c either to the protein itself or to its tag (polyclonal anti-RAP74, N-16, Santa Cruz Biotechnology; monoclonal anti-GST, B-14, Santa Cruz Biotechnology; monoclonal anticycD1, Ab-3, CalBiochem).
Western blot analysis
All Western blots were performed according to standard techniques, as described (Harlow and Lane, 1988) .
